2bmw | pdb_00002bmw

FERREDOXIN: NADP+REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA 160 REPLACED BY THR, LEU 263 REPLACED BY PRO, ARG 264 REPLACED BY PRO AND GLY 265 REPLACED BY PRO (T155G-A160T-L263P-R264P-G265P)

spinqualitylabelsall models 2bmw, resolution 1.50Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 2bmw is a 1 chain structure with sequence from Anabaena sp.. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Ligands: FAD, SO4 Related: 1b2r, 1bjk, 1bqe, 1e62, 1e63, 1e64, 1ewy, 1gjr, 1go2, 1gr1, 1h42, 1h85, 1ogi, 1ogj, 1qgy, 1qgz, 1qh0, 1que, 1quf, 1w34, 1w35, 1w87, 2bsa Activity: Ferredoxin--NADP(+) reductase, with EC number 1.18.1.2 Resources: FirstGlance, OCA, RCSB, PDBsum Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMed Helicobacter pylori flavodoxin is the electronic acceptor of the pyruvate-oxidoreductase complex (POR) that catalyzes pyruvate oxidative decarboxilation. Inactivation of this metabolic route precludes bacterial survival. Because flavodoxin is not present in the human host, substances interfering electronic transport from POR might be well suited for eradication therapies against the bacterium. H. pylori flavodoxin presents a peculiar cofactor (FMN) binding site, compared to other known flavodoxins, where a conserved aromatic residue is replaced by alanine. A cavity thus appears under the cofactor that can be filled with small organic molecules. We have cloned H. pylori fldA gene, expressed the protein in Escherichia coli and characterized the purified flavodoxin. Thermal up-shift assays of flavodoxin with different concentrations of benzylamine, as well as fluorescence titration experiments indicate benzylamine binds in the pocket near the FMN binding site. It seems thus that low affinity inhibitors of H. pylori flavodoxin can be easily found that, after improvement, may give rise to leads. Towards a new therapeutic target: Helicobacter pylori flavodoxin.,Cremades N, Bueno M, Toja M, Sancho J Biophys Chem. 2005 Apr 1;115(2-3):267-76. Epub 2005 Jan 7. PMID:15752617 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Proteopedia Page Contributors and Editors (what is this?)

OCA